Dr. Paul Whelton's research interests include cardiovascular and renal disease epidemiology, prevention, clinical trials, health policy, and global health. He has led many of the major NIH-funded blood pressure intervention trials, including the Trials of Hypertension Prevention (TOHP, Phases I and II), the Trial of Nonpharmacologic Intervention in the Elderly (TONE), the Antihypertensive and Lipid-Lowering to Prevent Heart Attack Trial (ALLHAT), and the Systolic Blood Pressure Intervention Trial (SPRINT). He chaired the 2017 ACC/AHA Guideline Writing Committee for Prevention, Detection, Evaluation, and Management of High Blood Pressure, as well as many working groups and committees for institutes at the NIH, the American Heart Association, the Institute of Medicine, the Irish Government, and the Show Chwan Health System in Taiwan. Amongst many awards and honors, he received the American Heart Association Population Research Prize. He has published more than 400 peer-reviewed manuscripts and 70 books, book chapters, supplements, or monographs.